Related references
Note: Only part of the references are listed.Decoy receptors block TRAIL sensitivity at a supracellular level: the role of stromal cells in controlling tumour TRAIL sensitivity
L. O'Leary et al.
ONCOGENE (2016)
Poly-ubiquitination in TNFR1-mediated necroptosis
Yves Dondelinger et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Melanoma-Directed Activation of Apoptosis Using a Bispecific Antibody Directed at MCSP and TRAIL Receptor-2/Death Receptor-5
Yuan He et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2016)
Structural Insight for Roles of DR5 Death Domain Mutations on Oligomerization of DR5 Death Domain-FADD Complex in the Death-Inducing Signaling Complex Formation: A Computational Study
Hongyi Yang et al.
JOURNAL OF MOLECULAR MODELING (2016)
Caspase 8 expression may determine the survival of women with ovarian cancer
M. Kim et al.
CELL DEATH & DISEASE (2016)
The cleaved FAS ligand activates the Na+/H+ exchanger NHE1 through Akt/ROCK1 to stimulate cell motility
Michael Monet et al.
SCIENTIFIC REPORTS (2016)
Cancer Cell-Autonomous TRAIL-R Signaling Promotes KRAS-Driven Cancer Progression, Invasion, and Metastasis
Silvia von Karstedt et al.
CANCER CELL (2015)
Targeting the extrinsic apoptotic pathway in cancer: lessons learned and future directions
Avi Ashkenazi
JOURNAL OF CLINICAL INVESTIGATION (2015)
From mice to humans: developments in cancer immunoediting
Michele W. L. Teng et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
H3K9 Trimethylation Silences Fas Expression To Confer Colon Carcinoma Immune Escape and 5-Fluorouracil Chemoresistance
Amy V. Paschall et al.
JOURNAL OF IMMUNOLOGY (2015)
RIP1 Cleavage in the Kinase Domain Regulates TRAIL-Induced NFκB Activation and Lymphoma Survival
Laiqun Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2015)
Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes
Henriette Ebsen et al.
MOLECULAR IMMUNOLOGY (2015)
Effect of DR4 promoter methylation on the TRAIL-induced apoptosis in lung squamous carcinoma cell
Wenwu Wang et al.
ONCOLOGY REPORTS (2015)
DED or alive: assembly and regulation of the death effector domain complexes
J. S. Riley et al.
CELL DEATH & DISEASE (2015)
Granzyme A activates another way to die
Judy Lieberman
IMMUNOLOGICAL REVIEWS (2015)
Going Back to Class I: MHC and Immunotherapies for Childhood Cancer
Kellie B. Haworth et al.
PEDIATRIC BLOOD & CANCER (2015)
Molecular mechanisms of natural killer cell activation in response to cellular stress
C. J. Chan et al.
CELL DEATH AND DIFFERENTIATION (2014)
Building blocks of the apoptotic pore: how Bax and Bak are activated and oligomerize during apoptosis
D. Westphal et al.
CELL DEATH AND DIFFERENTIATION (2014)
Getting TRAIL back on track for cancer therapy
J. Lemke et al.
CELL DEATH AND DIFFERENTIATION (2014)
New insights into cancer immunoediting and its three component phases elimination, equilibrium and escape
Deepak Mittal et al.
CURRENT OPINION IN IMMUNOLOGY (2014)
Die another way - non-apoptotic mechanisms of cell death
Stephen W. G. Tait et al.
JOURNAL OF CELL SCIENCE (2014)
True Grit: Programmed Necrosis in Antiviral Host Defense, Inflammation, and Immunogenicity
Edward S. Mocarski et al.
JOURNAL OF IMMUNOLOGY (2014)
Inhibition of PP2A Activity Confers a TRAIL-Sensitive Phenotype during Malignant Transformation
Hongmei Yang et al.
MOLECULAR CANCER RESEARCH (2014)
Mixed Lineage Kinase Domain-like Protein MLKL Causes Necrotic Membrane Disruption upon Phosphorylation by RIP3
Huayi Wang et al.
MOLECULAR CELL (2014)
Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
Zhenyu Cai et al.
NATURE CELL BIOLOGY (2014)
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Tom Vanden Berghe et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Necroptotic signaling in adaptive and innate immunity
Jennifer V. Lu et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2014)
Functions of caspase 8: The identified and the mysterious
Guy S. Salvesen et al.
SEMINARS IN IMMUNOLOGY (2014)
HAX1 regulates E3 ubiquitin ligase activity of cIAPs by promoting their dimerization
Jin Sun Choi et al.
ONCOTARGET (2014)
MLKL Compromises Plasma Membrane Integrity by Binding to Phosphatidylinositol Phosphates
Yves Dondelinger et al.
CELL REPORTS (2014)
How do CD4+ T cells detect and eliminate tumor cells that either lack or express MHC class II molecules?
Ole Audun Werner Haabeth et al.
FRONTIERS IN IMMUNOLOGY (2014)
X-linked inhibitor of apoptosis protein - a critical death resistance regulator and therapeutic target for personalized cancer therapy
Petra Obexer et al.
FRONTIERS IN ONCOLOGY (2014)
Translating TRAIL-receptor targeting agents to the clinic
Martha W. den Hollander et al.
CANCER LETTERS (2013)
Loss of Caspase-8 in Hepatocytes Accelerates the Onset of Liver Regeneration in Mice Through Premature Nuclear Factor kappa B Activation
Julia Freimuth et al.
HEPATOLOGY (2013)
'Decoy' and 'non-decoy' functions of DcR3 promote malignant potential in human malignant fibrous histiocytoma cells
Mitsunori Toda et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Natural killer cell biology: An update and future directions
Kerry S. Campbell et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2013)
Structural determinants of DISC function: New insights into death receptor-mediated apoptosis signalling
Tamas Sessler et al.
PHARMACOLOGY & THERAPEUTICS (2013)
The MHC I loading complex: a multitasking machinery in adaptive immunity
Sabine Hulpke et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Location and cellular stages of natural killer cell development
Jianhua Yu et al.
TRENDS IN IMMUNOLOGY (2013)
Death Receptor-Ligand Systems in Cancer, Cell Death, and Inflammation
Henning Walczak
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Resistance to TRAIL in non-transformed cells is due to multiple redundant pathways
M. van Dijk et al.
CELL DEATH & DISEASE (2013)
Natural killer cell mediated antibody-dependent cellular cytotoxicity in tumor immunotherapy with therapeutic antibodies
Ursula J. E. Seidel et al.
FRONTIERS IN IMMUNOLOGY (2013)
Immune surveillance of senescent cells-biological significance in cancer- and non-cancer pathologies
Lisa Hoenicke et al.
CARCINOGENESIS (2012)
CD95-mediated cell signaling in cancer: mutations and post-translational modulations
Sebastien Tauzin et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2012)
CD4(+)T Cells: Differentiation and Functions
Rishi Vishal Luckheeram et al.
CLINICAL & DEVELOPMENTAL IMMUNOLOGY (2012)
Expression of c-FLIP in malignant melanoma, and its relationship with the clinicopathological features of the disease
F. Tian et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2012)
Elevation of c-FLIP in Castrate-Resistant Prostate Cancer Antagonizes Therapeutic Response to Androgen Receptor-Targeted Therapy
Clare McCourt et al.
CLINICAL CANCER RESEARCH (2012)
Kinome profiling of non-canonical TRAIL signaling reveals RIP1-Src-STAT3-dependent invasion in resistant non-small cell lung cancer cells
Kaamar Azijli et al.
JOURNAL OF CELL SCIENCE (2012)
Natural Killer Cell Tolerance: Control by Self or Self-Control?
Baptiste N. Jaeger et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Decoy receptor 3: A pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer
Wan-Wan Lin et al.
BIOCHEMICAL PHARMACOLOGY (2011)
Recurrence-Free Survival in Prostate Cancer Is Related to Increased Stromal TRAIL Expression
Mariam Anees et al.
CANCER (2011)
BID is cleaved by caspase-8 within a native complex on the mitochondrial membrane
Z. T. Schug et al.
CELL DEATH AND DIFFERENTIATION (2011)
Cell Surface Delivery of TRAIL Strongly Augments the Tumoricidal Activity of T Cells
Marco de Bruyn et al.
CLINICAL CANCER RESEARCH (2011)
Tumor necrosis factor receptor cross-talk
Petrus J. W. Naude et al.
FEBS JOURNAL (2011)
Cellular Inhibitors of Apoptosis Proteins cIAP1 and cIAP2 Are Required for Efficient Caspase-1 Activation by the Inflammasome
Katherine Labbe et al.
IMMUNITY (2011)
Activating and inhibitory receptors of natural killer cells
Hollie J. Pegram et al.
IMMUNOLOGY AND CELL BIOLOGY (2011)
Expression of MICA, MICB and NKG2D in human leukemic myelomonocytic and cervical cancer cells
Benny Weiss-Steider et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2011)
CD95 triggers Orai1-mediated localized Ca2+ entry, regulates recruitment of protein kinase C (PKC) β2, and prevents death-inducing signaling complex formation
Nadine Khadra et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
The role of c-FLIP splice variants in urothelial tumours
F. Ewald et al.
CELL DEATH & DISEASE (2011)
The Naturally Processed CD95L Elicits a c-Yes/Calcium/PI3K-Driven Cell Migration Pathway
Sebastien Tauzin et al.
PLOS BIOLOGY (2011)
Differentiation of Effector CD4 T Cell Populations
Jinfang Zhu et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Survivin and IAP proteins in cell-death mechanisms
Dario C. Altieri
BIOCHEMICAL JOURNAL (2010)
Mutant PIK3CA licenses TRAIL and CD95L to induce non-apoptotic caspase-8-mediated ROCK activation
M. Ehrenschwender et al.
CELL DEATH AND DIFFERENTIATION (2010)
Expression, Cellular Distribution, and Prognostic Relevance of TRAIL Receptors in Hepatocellular Carcinoma
Lydia Kriegl et al.
CLINICAL CANCER RESEARCH (2010)
Oncogenic K-Ras Turns Death Receptors Into Metastasis-Promoting Receptors in Human and Mouse Colorectal Cancer Cells
Frederik J. H. Hoogwater et al.
GASTROENTEROLOGY (2010)
Signaling to NF-κB: Regulation by Ubiquitination
Ingrid E. Wertz et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
The role of CD4 T cell help for CD8 CTL activation
Sheng Zhang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
The cytotoxic T lymphocyte protease granzyme A cleaves and inactivates poly(adenosine 5′-diphosphate-ribose) polymerase-1
Pengcheng Zhu et al.
BLOOD (2009)
TRAIL receptor signalling and modulation: Are we on the right TRAIL?
Devalingam Mahalingam et al.
CANCER TREATMENT REVIEWS (2009)
Role of full-length osteoprotegerin in tumor cell biology
G. Zauli et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Life and death by death receptors
Maria Eugenia Guicciardi et al.
FASEB JOURNAL (2009)
CD56bright natural killer (NK) cells: an important NK cell subset
Aurelie Poli et al.
IMMUNOLOGY (2009)
Mechanisms by which Bak and Bax permeabilise mitochondria during apoptosis
Grant Dewson et al.
JOURNAL OF CELL SCIENCE (2009)
Low FAS/CD95 Expression by CTCL Correlates with Reduced Sensitivity to Apoptosis that Can Be Restored by FAS Upregulation
Jianqiang Wu et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Membrane-bound Fas ligand only is essential for Fas-induced apoptosis
Lorraine A. O' Reilly et al.
NATURE (2009)
Flk2+ common lymphoid progenitors possess equivalent differentiation potential for the B and T lineages
Holger Karsunky et al.
BLOOD (2008)
Yes and PI3K bind CD95 to signal invasion of glioblastoma
Susanne Kleber et al.
CANCER CELL (2008)
DOCK10-Mediated Cdc42 Activation Is Necessary for Amoeboid Invasion of Melanoma Cells
Gilles Gadea et al.
CURRENT BIOLOGY (2008)
Transformation, translation and TRAIL: An unexpected intersection.
Shai White-Gilbertson et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
TRAU-R deficiency in mice promotes susceptibility to chronic inflammation and tumorigenesis
Niklas Finnberg et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Bcl-2 family proteins and cancer
K. W. Yip et al.
ONCOGENE (2008)
NK cells and cancer immunosurveillance
I. Waldhauer et al.
ONCOGENE (2008)
Mechanisms of granule-dependent killing
S. P. Cullen et al.
CELL DEATH AND DIFFERENTIATION (2008)
Investigating the interaction between osteoprotegerin and receptor activator of NF-κB or tumor necrosis factor-related apoptosis-inducing ligand
Srdjan Vitovski et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
An elaborate pathway required for Ras-mediated epigenetic silencing
Claude Gazin et al.
NATURE (2007)
ADAM10 regulates FasL cell surface expression and modulates FasL-induced cytotoxicity and activation-induced cell death
M. Schulte et al.
CELL DEATH AND DIFFERENTIATION (2007)
Matrix metalloproteinase-9 regulates TNF-α and FasL expression in neuronal, glial cells and its absence extends life in a transgenic mouse model of amyotrophic lateral sclerosis
Mahmoud Kiaei et al.
EXPERIMENTAL NEUROLOGY (2007)
Human and murine granzyme B exhibit divergent substrate preferences
Sean P. Cullen et al.
JOURNAL OF CELL BIOLOGY (2007)
Three is better than one: Pre-ligand receptor assembly in the regulation of TNF receptor signaling
Francis Ka-Ming Chan
CYTOKINE (2007)
Methylation of CASP8, DCR2, and HIN-1 in neuroblastoma is associated with poor outcome
Qiwei Yang et al.
CLINICAL CANCER RESEARCH (2007)
Interferons, immunity and cancer immunoediting
Gavin P. Dunn et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Designed tumor necrosis factor-related apoptosis-inducing ligand variants initiating apoptosis exclusively via the DR5 receptor
Almer M. van der Sloot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
tRAIL receptor-mediated JNK activation and Bim phosphorylation critically regulate Fas-mediated liver damage and lethality
Nadia Corazza et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Cytotoxic T cells
Mads Hald Andersen et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Does CD95 have tumor promoting activities?
ME Peter et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2005)
Structure of the apoptotic protease-activating factor 1 bound to ADP
SJ Riedl et al.
NATURE (2005)
Infrequent mutation of TRAIL receptor 2 (TRAIL-R2/DR5) in transitional cell carcinoma of the bladder with 8p21 loss of heterozygosity
J Adams et al.
CANCER LETTERS (2005)
Increased sensitivity to TRAIL-induced apoptosis occurs during the adenoma to carcinoma transition of colorectal carcinogenesis
A Hague et al.
BRITISH JOURNAL OF CANCER (2005)
The cell biology of the human natural killer cell CD94/NKG2A inhibitory receptor
F Borrego et al.
MOLECULAR IMMUNOLOGY (2005)
N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-κB signaling pathway
T Kataoka et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action
CR Yang et al.
CANCER RESEARCH (2004)
Tumor necrosis factor-related apoptosis-inducing ligand can induce apoptosis in subsets of premalignant cells
XJ Lu et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Oncogenic ras sensitizes normal human cells to tumor necrosis factor-α-related apoptosis-inducing ligand-induced apoptosis
A Nesterov et al.
CANCER RESEARCH (2004)
Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy
A Almasan et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2003)
Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor
ZS Fan et al.
CELL (2003)
Anti-CD95-induced lethality requires radioresistant FcγRII+ cells -: A novel mechanism for fulminant hepatic failure
S Jodo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Hypermethylation of the gene promoter and enhancer region can regulate Fas expression and sensitivity in colon carcinoma
I Petak et al.
CELL DEATH AND DIFFERENTIATION (2003)
The caspase 8 inhibitor c-FLIPL modulates T-cell receptor-induced proliferation but not activation-induced cell death of lymphocytes
SMA Lens et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Mutation of the DR5/TRAIL receptor 2 gene is infrequent in hepatocellular carcinoma
YM Jeng et al.
CANCER LETTERS (2002)
Increased susceptibility to tumor initiation and metastasis in TNF-related apoptosis-inducing ligand-deficient mice
E Cretney et al.
JOURNAL OF IMMUNOLOGY (2002)
Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development
K Takeda et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Differential inactivation of caspase-8 in lung cancers
N Shivapurkar et al.
CANCER BIOLOGY & THERAPY (2002)
Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks
PJ Beresford et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Inactivating mutations of KILLER/DR5 gene in gastric cancers
WS Park et al.
GASTROENTEROLOGY (2001)
MICA and MICB genes:: can the enigma of their polymorphism be resolved?
HAF Stephens
TRENDS IN IMMUNOLOGY (2001)
Apoptotic death sensor: an organelle's alter ego?
SB Bratton et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2001)
Inhibition of natural killer cell activation signals by killer cell immunoglobulin-like receptors (CD158)
EO Long et al.
IMMUNOLOGICAL REVIEWS (2001)
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
D Lawrence et al.
NATURE MEDICINE (2001)
Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma
SH Lee et al.
ONCOGENE (2001)
Initiation of apoptosis by granzyme B requires direct cleavage of Bid, but not direct granzyme B-mediated caspase activation
VR Sutton et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling
FKM Chan et al.
SCIENCE (2000)
Fas preassociation required for apoptosis signaling and dominant inhibition by pathogenic mutations
RM Siegel et al.
SCIENCE (2000)
Share Paper
